Fluctuating Encephalopathy With Bulbar Dysfunction and Sleep‐Disordered Breathing: A Diagnostic Challenge Highlighting a Treatable Autoimmune Mimic of Neurodegenerative Disease
Year: 2026
Type: article
Study design: Case Report
Abstract: Anti‐IgLON5 disease is a rare neurological disorder with overlapping autoimmune and neurodegenerative features, often leading to delayed diagnosis due to phenotypic heterogeneity. Early identification of immune‐dominant cases is crucial, as they may respond to immunotherapy. We report a 67‐year‐old male presenting with progressive bulbar dysfunction, sleep‐disordered breathing, and intermittent hypercapnic respiratory failure over 6 months. Structural neuroimaging and cerebrospinal fluid analysis were unremarkable. FDG‐PET brain imaging suggested a neurodegenerative pattern; however, preserved dopaminergic uptake on 18F‐DOPA PET did not support a significant presynaptic nigrostriatal dopaminergic deficit. Polysomnography confirmed severe obstructive sleep apnea with nocturnal hypoventilation. Serum anti‐IgLON5 antibodies were very strongly positive on a tissue‐based assay using indirect immunofluorescence at a 1:10 dilution and were subsequently confirmed by a cell‐based assay. CSF anti‐IgLON5 antibody testing was not performed. Serum neurofilament light polypeptide was measured by sandwich enzyme‐linked immunosorbent assay (ELISA) and was reported as “not detected”; the laboratory did not provide a numerical lower limit of detection. The patient was treated with intravenous methylprednisolone, intravenous immunoglobulin, and rituximab, resulting in clinically meaningful improvement. This case highlights the importance of recognizing immune‐dominant anti‐IgLON5 disease. Multimodal imaging and biomarkers can differentiate it from neurodegenerative disorders, enabling early immunotherapy and improved outcomes.
DOI: 10.1002/ncn3.70176
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Keywords: anti-IgLON5 disease, bulbar dysfunction, sleep-disordered breathing, obstructive sleep apnea, hypercapnic respiratory failure, autoimmune encephalitis, immunotherapy, rituximab, intravenous immunoglobulin, methylprednisolone, neurofilament light chain, FDG-PET, 18F-DOPA PET, differential diagnosis
Open Access status: bronze
OpenAlex ID: W7236448247
